摘要
甘油三酯葡萄糖指数已被认为是一种简便特异的衡量胰岛素抵抗的可靠指标,而甘油三酯葡萄糖-体重指数(TyG-BMI)则是甘油三酯葡萄糖指数与肥胖相结合所产生的更强有力的胰岛素抵抗替代标志物。TyG-BMI与心血管及代谢性疾病的严重程度和不良预后之间的相关性日益引起人们的重视。现阐述TyG-BMI在高血压、冠状动脉粥样硬化性心脏病、糖尿病、高尿酸血症和非酒精性脂肪性肝病中的临床应用价值和最新研究进展。
The triglyceride glucose index has been suggested as a simple and specific indicator of insulin resistance,and triglyceride glucose-body mass index(TyG-BMI)is an even stronger proxy for insulin resistance when combined with obesity.The correlation between TyG-BMI and the severity and poor prognosis of cardiovascular and metabolic diseases is increasingly receiving attention.This article describes the clinical application value and latest research progress of TyG-BMI in hypertension,coronary atherosclerotic heart disease,diabetes,hyperuricemia and non-alcoholic fatty liver disease.
作者
宋珂
王毅
潘三葱
SONG Ke;WANG Yi;PAN Sancong(Changzhi Medical College,Changzhi 046000,Shanxi,China;Department of Cardiovascular Medicine,Jincheng People’s Hospital,Jincheng 048000,Shanxi,China)
出处
《心血管病学进展》
CAS
2024年第7期636-641,共6页
Advances in Cardiovascular Diseases
基金
晋城市科技局科技攻关项目(20220207)。
